• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不可手术的慢性血栓栓塞性肺动脉高压患者的死亡率预测因素。

Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension.

机构信息

Department of Pulmonary Diseases, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Respir Med. 2009 Jul;103(7):1013-9. doi: 10.1016/j.rmed.2009.01.017. Epub 2009 Feb 20.

DOI:10.1016/j.rmed.2009.01.017
PMID:19230641
Abstract

INTRODUCTION

Recent studies suggest that medically treated patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) have an improved prognosis. However, only limited data are available concerning predictors of mortality in these patients. The aim of this study was to assess, and to identify, predictors of the long-term outcome of inoperable CTEPH patients.

METHODS

We analysed 84 inoperable CTEPH patients referred to our centre between 1999 and 2008. During follow-up (mean 32 months), 17 patients died and one underwent a lung transplantation. The 1-, 3- and 5-year survival rates were 93, 78 and 68%, respectively. Univariate analysis demonstrated that 6-min walking distance (6MWD), mean pulmonary artery pressure (mPAP), right atrial pressure (RAP) and pulmonary vascular resistance (PVR) were predictive factors for survival. In the multivariate analysis only 6MWD was independently related to poor survival (hazard ratio 0.995; 95% CI, 0.991-0.998; P=0.003). Kaplan-Meier curves showed that patients with an mPAP>40 mmHg, PVR>584 dyn s cm(-5) and RAP>12 mmHg had a very poor prognosis.

CONCLUSIONS

Haemodynamic parameters (mPAP, RAP, PVR) and the 6MWD at baseline are predictive factors for mortality of medically treated inoperable CTEPH patients. A subgroup of these patients with good prognostic factors, defined by their haemodynamics and clinical measures, have an improved long-term survival and outcome.

摘要

介绍

最近的研究表明,患有无法手术的慢性血栓栓塞性肺动脉高压(CTEPH)的经医学治疗患者预后有所改善。然而,关于这些患者死亡的预测因素仅有有限的数据。本研究的目的是评估和确定无法手术的 CTEPH 患者的长期预后的预测因素。

方法

我们分析了 1999 年至 2008 年间转诊至我们中心的 84 例无法手术的 CTEPH 患者。在随访期间(平均 32 个月),17 例患者死亡,1 例患者接受了肺移植。1、3 和 5 年的生存率分别为 93%、78%和 68%。单因素分析表明,6 分钟步行距离(6MWD)、平均肺动脉压(mPAP)、右心房压(RAP)和肺血管阻力(PVR)是生存的预测因素。多因素分析显示,只有 6MWD 与较差的生存独立相关(危险比 0.995;95%可信区间,0.991-0.998;P=0.003)。Kaplan-Meier 曲线显示,mPAP>40mmHg、PVR>584dyn s cm(-5)和 RAP>12mmHg 的患者预后极差。

结论

基线时的血流动力学参数(mPAP、RAP、PVR)和 6MWD 是预测经医学治疗的无法手术的 CTEPH 患者死亡率的预测因素。通过血流动力学和临床测量定义具有良好预后因素的这些患者亚组具有改善的长期生存和预后。

相似文献

1
Predictors of mortality in inoperable chronic thromboembolic pulmonary hypertension.不可手术的慢性血栓栓塞性肺动脉高压患者的死亡率预测因素。
Respir Med. 2009 Jul;103(7):1013-9. doi: 10.1016/j.rmed.2009.01.017. Epub 2009 Feb 20.
2
Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.静脉注射依前列醇治疗无法手术的慢性血栓栓塞性肺动脉高压
J Heart Lung Transplant. 2007 Apr;26(4):357-62. doi: 10.1016/j.healun.2006.12.014.
3
Long-term outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a single institution experience.慢性血栓栓塞性肺动脉高压行肺动脉内膜剥脱术后的长期预后:单中心经验
Eur J Cardiothorac Surg. 2009 Jun;35(6):947-52; discussion 952. doi: 10.1016/j.ejcts.2009.01.023. Epub 2009 Mar 9.
4
[Chronic thromboembolic pulmonary hypertension: surgical treatment with thromboendarterectomy].[慢性血栓栓塞性肺动脉高压:肺动脉血栓内膜剥脱术的外科治疗]
Arch Bronconeumol. 2009 Oct;45(10):496-501. doi: 10.1016/j.arbres.2009.05.014. Epub 2009 Aug 5.
5
Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.波生坦治疗无法手术的慢性血栓栓塞性肺动脉高压:BENEFiT(波生坦对无法手术的慢性血栓栓塞性肺动脉高压形式的影响),一项随机、安慰剂对照试验。
J Am Coll Cardiol. 2008 Dec 16;52(25):2127-34. doi: 10.1016/j.jacc.2008.08.059.
6
Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.吸入伊洛前列素治疗慢性血栓栓塞性肺动脉高压后急性血流动力学改善
Respiration. 2008;76(2):154-9. doi: 10.1159/000107977. Epub 2007 Sep 5.
7
Predictors of long-term clinical outcome of patients with acute massive pulmonary embolism after thrombolytic therapy.急性大面积肺栓塞患者溶栓治疗后长期临床结局的预测因素
Chin Med J (Engl). 2003 Apr;116(4):503-9.
8
Predictors of outcome in chronic thromboembolic pulmonary hypertension.慢性血栓栓塞性肺动脉高压的预后预测因素
Circulation. 2007 Apr 24;115(16):2153-8. doi: 10.1161/CIRCULATIONAHA.106.661041. Epub 2007 Apr 9.
9
Japanese single-center experience of surgery for chronic thromboembolic pulmonary hypertension.日本单中心慢性血栓栓塞性肺动脉高压手术经验
Ann Thorac Surg. 2006 Aug;82(2):630-6. doi: 10.1016/j.athoracsur.2006.03.121.
10
Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ten years experience in Denmark.慢性血栓栓塞性肺动脉高压的肺动脉内膜剥脱术。丹麦的十年经验。
Scand Cardiovasc J. 2006 Feb;40(1):49-53. doi: 10.1080/14017430500338513.

引用本文的文献

1
Lung parenchymal and cardiac appearances on computed tomography pulmonary angiography impact survival in chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.计算机断层扫描肺动脉造影的肺实质和心脏表现对慢性血栓栓塞性肺动脉高压患者生存率的影响:来自ASPIRE注册研究的结果
ERJ Open Res. 2025 Jun 23;11(3). doi: 10.1183/23120541.00732-2024. eCollection 2025 May.
2
Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review of the Most Updated Literature.慢性血栓栓塞性肺动脉高压的肺动脉内膜剥脱术:最新文献的系统评价
J Clin Med. 2022 Nov 26;11(23):6976. doi: 10.3390/jcm11236976.
3
Prognostic Value of Pulmonary Artery Pulsatility Index in Right Ventricle Failure-Related Mortality in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
肺动脉搏动指数在无法手术的慢性血栓栓塞性肺动脉高压右心室衰竭相关死亡率中的预后价值
J Clin Med. 2022 May 12;11(10):2735. doi: 10.3390/jcm11102735.
4
End-Systolic Eccentricity Index Obtained by Enhanced Computed Tomography Is a Predictor of Pulmonary Vascular Resistance in Patients with Chronic Thromboembolic Pulmonary Hypertension.通过增强计算机断层扫描获得的收缩末期偏心指数是慢性血栓栓塞性肺动脉高压患者肺血管阻力的预测指标。
Life (Basel). 2022 Apr 17;12(4):593. doi: 10.3390/life12040593.
5
Chronic Thromboembolic Pulmonary Hypertension: An Update.慢性血栓栓塞性肺动脉高压:最新进展
Diagnostics (Basel). 2022 Jan 19;12(2):235. doi: 10.3390/diagnostics12020235.
6
Sex and survival following pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: a Scandinavian observational cohort study.慢性血栓栓塞性肺动脉高压患者接受肺动脉内膜剥脱术后的性别与生存情况:一项斯堪的纳维亚观察性队列研究
Pulm Circ. 2021 Oct 27;11(4):20458940211056014. doi: 10.1177/20458940211056014. eCollection 2021 Oct-Dec.
7
A Feasibility Study on Using Single-Photon Emission Computed Tomography Pulmonary Perfusion/Ventilation Imaging for the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension and Patient Risk Assessment.单光子发射计算机断层扫描肺灌注/通气成像用于慢性血栓栓塞性肺动脉高压诊断及患者风险评估的可行性研究
Int J Gen Med. 2021 Nov 10;14:8029-8038. doi: 10.2147/IJGM.S335051. eCollection 2021.
8
Risk prediction in medically treated chronic thromboembolic pulmonary hypertension.医学治疗的慢性血栓栓塞性肺动脉高压的风险预测。
BMC Pulm Med. 2021 Apr 20;21(1):128. doi: 10.1186/s12890-021-01495-6.
9
Correlation Between Perfusion Abnormalities Extent in Ventilation/Perfusion SPECT/CT with Hemodynamic Parameters in Patients with Chronic Thromboembolic Pulmonary Hypertension.慢性血栓栓塞性肺动脉高压患者通气/灌注单光子发射计算机断层扫描/计算机断层扫描中灌注异常范围与血流动力学参数的相关性
Mol Imaging Radionucl Ther. 2021 Feb 9;30(1):28-33. doi: 10.4274/mirt.galenos.2020.31932.
10
Riociguat Improves Pulmonary Hemodynamics in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension.利奥西呱可改善无法手术的慢性血栓栓塞性肺动脉高压患者的肺血流动力学。
Acta Cardiol Sin. 2020 Jan;36(1):64-71. doi: 10.6515/ACS.202001_36(1).20190612A.